心臓モニタリングおよび心臓リズム管理デバイス市場規模、シェア、動向、2031年までの世界予測

世界の心臓モニタリングおよび心臓リズム管理デバイス市場は、2026年の279億米ドルから2031年には378億8,000万米ドルに拡大し、予測期間中の年平均成長率（CAGR）は6.3%に達するとMarketsandMarketsでは予測しています。市場の成長は、心血管疾患の早期発見を目的とした啓発キャンペーンやスクリーニングプログラムの普及といった要因によって牽引されており、特に高リスク層における心臓モニタリングデバイスの需要増加につながっています。一方で、遠隔モニタリングや遠隔医療技術の導入は、データセキュリティや患者のプライバシーに関する懸念を引き起こしており、これらのデバイスの患者による受け入れや普及を妨げる可能性があります。

調査概要

本レポートは、心臓モニタリングおよび心臓リズム管理デバイス市場を、タイプ、用途、エンドユーザー、地域別に分析しています。また、市場成長に影響を与える要因、市場における様々な機会と課題、そして市場リーダーの競争環境についても詳細に解説しています。さらに、個々の成長傾向に基づいてマイクロ市場を分析し、5つの主要地域（および各地域内の各国）における市場セグメント別収益を予測しています。

本レポートを購入する理由

本レポートは、既存企業だけでなく新規参入企業や中小企業にとっても、市場の動向を把握し、より大きな市場シェアを獲得するのに役立ちます。本レポートを購入した企業は、以下の戦略のいずれか、または複数の戦略を組み合わせて、市場での存在感を強化することができます。

本レポートでは、以下のポイントについて考察します。

• 心臓モニタリングおよび心臓リズム管理デバイス市場の成長に影響を与える主要な推進要因（急速に拡大する世界的な高齢者人口とそれに伴う心疾患の増加、生活習慣病および心血管疾患の発生率の上昇）、阻害要因（急速に拡大する世界的な高齢者人口とそれに伴う心疾患の増加、生活習慣病および心血管疾患の発生率の上昇）、機会（新興市場における未開拓の成長可能性）、および課題（頻繁な製品リコール）の分析
• 市場浸透度：心臓モニタリングおよび心臓リズム管理デバイス市場における主要企業が提供する製品ポートフォリオに関する包括的な情報
• 製品開発／イノベーション：心臓モニタリングおよび心臓リズム管理デバイス市場における今後のトレンド、研究開発活動、および製品開発に関する詳細な考察
• 市場開発：有望な新興地域に関する包括的な情報
• 市場の多様化：新製品、成長地域、および最近の動向に関する包括的な情報心臓モニタリングおよび心臓リズム管理デバイス市場の動向
• 競合分析：主要市場プレーヤーの市場セグメント、成長戦略、収益分析、および製品に関する詳細な分析

Report Description

The global cardiac monitoring and cardiac rhythm management devices market is projected to reach USD 37.88 billion by 2031, up from USD 27.90 billion in 2026, growing at a CAGR of 6.3% over the forecast period. Market growth is driven by factors such as rising public awareness campaigns and screening programs aimed at early detection of cardiovascular diseases, which contribute to growing demand for cardiac monitoring devices, especially in high-risk populations. On the other hand, the adoption of remote monitoring and telemedicine technologies raises concerns about data security and patient privacy, which may hinder patient acceptance and adoption of these devices.

“The implantable cardioverter defibrillators accounted for the largest market share in the cardiac rhythm management device market, during the forecast period.”

By type, cardiac rhythm management devices in the market are classified into implantable cardioverter defibrillators and external defibrillators. In 2025, implantable cardioverter defibrillators accounted for a sizable market share because they provide continuous protection against sudden cardiac arrest by continuously monitor the heart’s rhythm and deliver appropriate therapy when needed, protecting against sudden cardiac arrest. This constant monitoring and intervention offer round-the-clock protection for patients at risk of life-threatening arrhythmias, whereas external defibrillators are typically used for acute interventions in emergencies. Likewise, Implantable defibrillators are implanted surgically or via minimally invasive procedures in patients at high risk of sudden cardiac death due to underlying cardiac conditions such as ventricular arrhythmias or cardiomyopathy. They are intended for long-term use and are suitable for patients who require ongoing arrhythmia management. In contrast, external defibrillators, such as automated external defibrillators (AEDs) or manual defibrillators used in hospitals, are used mainly for emergency resuscitation in cases of cardiac arrest.

The home care settings are projected to register the highest CAGR during the forecast period.”

In the cardiac monitoring and rhythm management devices market, the home care segment is the fastest-growing end user due to the growing shift toward remote patient monitoring and home-based cardiac care. Advances in wearable, portable, and connected devices enable continuous monitoring and rhythm management outside traditional clinical settings, improving patient convenience and outcomes. Additionally, rising prevalence of chronic cardiac conditions, an aging population, and efforts to reduce hospitalizations and healthcare costs are further accelerating the adoption of these devices in home care environments.

“The North American region accounted for the highest share.”

The global cardiac monitoring and cardiac rhythm management devices market is divided into four regions: North America, Asia-Pacific, Europe, and the Rest of the World. According to the regional analysis, the North American region is likely to retain a significant market share in 2025 and beyond. The North American market is being propelled by rising cases of heart disease, increased healthcare expenditure, and greater awareness of early disease diagnosis.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 32%, Tier 2 – 44%, and Tier 3 – 24%
• By Designation: C-level – 30%, D-level – 34%, and Others – 36%
• By Region: North America – 40%, Europe – 28%, Asia Pacific – 20%, and the Rest of the World – 12%

The prominent players in the GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (US), Baxter (US), Medtronic (Ireland), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (US), Stryker (US), NIHON KOHDEN CORPORATION (Japan), MicroPort Scientific Corporation (China), FUKUDA DENSHI (Japan), OSI Systems, Inc. (US), iRhythm Inc. (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), and AliveCor, Inc. (US) among others.

Research Coverage

This report studies the Cardiac monitoring and cardiac rhythm management devices market based on type, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets by their individual growth trends and forecasts market segment revenue for five central regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the market pulse, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (rapidly expanding global geriatric population and subsequent surge in cardiac diseases, increasing incidence of lifestyle and cardiovascular diseases), restraints (rapidly expanding global geriatric population and subsequent surge in cardiac diseases
• Increasing incidence of lifestyle and cardiovascular diseases), opportunities (untapped growth potential in emerging markets), and challenges (frequent product recalls) influencing the growth of the cardiac monitoring and cardiac rhythm management devices market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Cardiac monitoring and cardiac rhythm management devices market
• Product  Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product developments in the Cardiac monitoring and cardiac rhythm management devices market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Cardiac monitoring and cardiac rhythm management devices market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

Table of Contents

1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.3 TUDY SCOPE 44
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 44
1.3.2 INCLUSIONS & EXCLUSIONS 45
1.3.3 YEARS CONSIDERED 45
1.3.4 CURRENCY CONSIDERED 46
1.4 STAKEHOLDERS 46
1.5 SUMMARY OF CHANGES 47
2 EXECUTIVE SUMMARY 48
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 48
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 50
2.3 DISRUPTIVE TRENDS IN MARKET 51
2.4 HIGH-GROWTH SEGMENTS 52
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 53
3 PREMIUM INSIGHTS 54
3.1 CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET OVERVIEW 54
3.2 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION AND COUNTRY 55
3.3 GEOGRAPHIC SNAPSHOT OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 56
4 MARKET OVERVIEW 57
4.1 INTRODUCTION 57
4.2 MARKET DYNAMICS 57
4.2.1 DRIVERS 58
4.2.1.1 Rising geriatric population with chronic cardiovascular diseases 58
4.2.1.2 Increasing incidence of lifestyle and cardiovascular diseases 58
4.2.1.3 Development of wireless monitoring and wearable cardiac devices 59
4.2.1.4 Rapid adoption of leadless pacemakers 59
4.2.1.5 Increasing focus on providing public-access defibrillators 60
4.2.2 RESTRAINTS 61
4.2.2.1 Increasing regulatory scrutiny extending time-to-market for cardiac devices 61
4.2.2.2 High device costs and reimbursement gaps 61

4.2.3 OPPORTUNITIES 61
4.2.3.1 Untapped growth potential in emerging markets 61
4.2.3.2 Emergence of leadless CRT platforms 62
4.2.4 CHALLENGES 62
4.2.4.1 Frequent product recalls 62
4.3 UNMET NEEDS & WHITE SPACES 63
4.3.1 UNMET NEEDS 63
4.3.2 WHITE SPACE OPPORTUNITIES 64
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 64
4.4.1 INTERCONNECTED MARKETS 64
4.4.2 CROSS-SECTOR OPPORTUNITIES 65
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 66
4.5.1 KEY STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 66
5 INDUSTRY TRENDS 67
5.1 PORTER’S FIVE FORCES ANALYSIS 67
5.1.1 THREAT OF NEW ENTRANTS 68
5.1.2 THREAT OF SUBSTITUTES 68
5.1.3 BARGAINING POWER OF BUYERS 69
5.1.4 BARGAINING POWER OF SUPPLIERS 69
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.2 MACROECONOMICS OUTLOOK 69
5.2.1 GDP TRENDS AND FORECAST 69
5.2.2 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 70
5.2.3 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 71
5.3 SUPPLY CHAIN ANALYSIS 71
5.4 VALUE CHAIN ANALYSIS 72
5.5 ECOSYSTEM ANALYSIS 73
5.5.1 ROLE IN ECOSYSTEM 74
5.6 PRICING ANALYSIS 74
5.6.1 AVERAGE SELLING PRICE TREND OF CARDIAC MONITORING DEVICES,
BY KEY PLAYER, 2024 AND 2025 (USD) 75
5.6.1.1 Average selling price of Holter monitors, by key player, 2025 75
5.6.1.2 Average selling price of external defibrillators, by key player, 2024 76
5.6.2 AVERAGE SELLING PRICE TREND OF CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION, 2023–2025 76
5.7 TRADE ANALYSIS 77
5.7.1 IMPORT DATA FOR HS CODE 901811, 2021–2024 78
5.7.2 EXPORT DATA FOR HS CODE 901811, 2021–2024 78
5.8 KEY CONFERENCES & EVENTS, 2025–2026 79
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 79
5.10 INVESTMENT & FUNDING SCENARIO 80
5.11 CASE STUDY ANALYSIS 81
5.11.1 DUAL-CHAMBER LEADLESS PACEMAKER BY ABBOTT 81
5.11.2 CARDIOSOFT ECG-BICESTER HEALTH CENTRE IN NUMED HEALTHCARE 81
5.11.3 POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT 82
5.12 IMPACT OF 2025 US TARIFF ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 83
5.12.1 KEY TARIFF RATES 84
5.12.2 PRICE IMPACT ANALYSIS 84
5.12.3 IMPACT ON COUNTRY/REGION 85
5.12.4 IMPACT ON END-USE INDUSTRIES 87
6 DSTRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTIONS 89
6.1 TECHNOLOGY ANALYSIS 89
6.1.1 KEY EMERGING TECHNOLOGIES 89
6.1.1.1 Artificial intelligence (AI) and predictive analytics 89
6.1.1.2 Miniaturization of cardiac devices 89
6.1.2 COMPLEMENTARY TECHNOLOGIES 90
6.1.2.1 Wearable biosensors 90
6.1.3 ADJACENT TECHNOLOGIES 90
6.1.3.1 Vital sign monitors 90
6.2 TECHNOLOGY/PRODUCT ROADMAP 91
6.2.1 NEAR TERM (2025–2027) 91
6.2.2 MID TERM (2028–2030) 91
6.2.3 LONG TERM (2030+) 92
6.3 PATENT ANALYSIS 92
6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS 92
6.4 FUTURE APPLICATIONS 95
6.4.1 FULLY AUTONOMOUS CARDIAC DIAGNOSTICS & DECISION-SUPPORT ECOSYSTEMS 95
6.4.2 PRECISION RHYTHM MANAGEMENT THROUGH PREDICTIVE & PRE-EMPTIVE THERAPY DELIVERY 95
6.4.3 FULLY LEADLESS, MODULAR, AND WIRELESSLY NETWORKED CARDIAC SYSTEMS 95
6.4.4 REGENERATIVE-INTEGRATED RHYTHM MANAGEMENT SYSTEMS 95
6.5 IMPACT OF AI/GEN AI ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 96
6.5.1 MARKET POTENTIAL OF AI 96
6.5.2 AI USE CASES 96
6.5.3 KEY COMPANIES IMPLEMENTING AI 98
6.5.4 BEST PRACTICES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 99
6.5.5 CASE STUDIES OF AI IMPLEMENTATION 100
6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 101
6.5.7 CLIENTS’ READINESS TO ADOPT GENERATIVE AI 102
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 103
7.1 REGULATORY LANDSCAPE 103
7.1.1 REGULATORY FRAMEWORK 103
7.1.1.1 North America 103
7.1.1.2 Europe 103
7.1.1.3 Asia Pacific 103
7.1.1.4 Latin America 103
7.1.1.5 Middle East & Africa 103
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
7.1.3 INDUSTRY STANDARDS 107
7.2 SUSTAINABILITY INITIATIVES 107
7.2.1 RECYCLABLE BIOMATERIALS FOR ECG PATCHES 107
7.2.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 108
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 108
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 110
8.1 KEY STAKEHOLDERS & BUYING CRITERIA 110
8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 110
8.1.2 BUYING CRITERIA 111
8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 111
8.2.1 DECISION-MAKING PROCESS 111
8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 112
8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 113
8.2.4 MARKET PROFITABILITY 113
9 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE 115
9.1 INTRODUCTION 116
9.2 PACEMAKERS 116
9.2.1 SINGLE-CHAMBER PACEMAKERS 118
9.2.1.1 Increasing use of single-chamber pacemakers for managing bradyarrhythmias and conduction disorders to aid market growth 118
9.2.2 DUAL-CHAMBER PACEMAKERS 120
9.2.2.1 Dual-chamber pacemakers to witness high demand with widespread usage 120
9.2.3 LEADLESS CHAMBER PACEMAKERS 122
9.2.3.1 Focus on minimally invasive implantation and reduced complication rates to propel market growth 122

9.3 DEFIBRILLATORS 124
9.3.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) 126
9.3.1.1 Single-chamber implantable cardioverter-defibrillators (ICDs) 129
9.3.1.1.1 Utilization in arterial monitoring to support market growth 129
9.3.1.2 Dual-chamber implantable cardioverter-defibrillators (ICDs) 131
9.3.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market 131
9.3.1.3 Subcutaneous implantable cardioverter-defibrillators (ICDs) 133
9.3.1.3.1 Benefits of eliminating cardiac leads to drive market 133
9.3.2 EXTERNAL DEFIBRILLATORS 135
9.3.2.1 Automated external defibrillators (AEDs) 137
9.3.2.1.1 Smart automated external defibrillators advancing public cardiac emergency response to aid market growth 137
9.3.2.2 Manual external defibrillators 139
9.3.2.2.1 Innovation in manual external defibrillators to enhance emergency cardiac care 139
9.3.2.3 Wearable cardioverter defibrillators (WCDs) 141
9.3.2.3.1 Operational difficulties and false alarms to restrain market adoption 141
9.4 CARDIAC RESYNCHRONIZATION THERAPY (CRT) 143
9.4.1 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) 143
9.4.2 CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS (CRT-D) 145
10 CARDIAC MONITORING DEVICES MARKET, BY TYPE 147
10.1 INTRODUCTION 148
10.2 NON-INVASIVE CARDIAC MONITORING DEVICES 148
10.2.1 ELECTROCARDIOGRAM (ECG/EKG) MONITORS 148
10.2.1.1 Standard 12-lead ECG machines (resting ECG monitors) 151
10.2.1.1.1 Wide availability of resting ECG devices to support market growth 151
10.2.1.2 Stress ECG systems 153
10.2.1.2.1 High cost of stress ECG devices to limit adoption 153
10.2.1.3 Handheld/Smart ECG monitors 155
10.2.1.3.1 Rising adoption of AI technology and growing need to minimize treatment costs to support market growth 155
10.2.2 AMBULATORY CARDIAC MONITORS 157
10.2.2.1 Holter monitors 159
10.2.2.1.1 Growing demand for continuous monitoring to fuel segment growth 159
10.2.2.2 Event monitors 161
10.2.2.2.1 Increasing outsourcing of monitoring devices to propel market growth 161
10.2.2.3 Mobile cardiac telemetry (MCT) devices 163
10.2.2.3.1 Increasing demand for cardiac monitoring solutions in home care settings to aid segment growth 163
10.2.2.4 Long-term continuous ECG monitors 165
10.2.2.4.1 Increasing adoption of patch-based ECG monitors for extended ambulatory cardiac monitoring to aid market growth 165
10.3 INVASIVE CARDIAC MONITORING DEVICES 167
10.3.1 INTRODUCTION OF TECHNOLOGICALLY ADVANCED IMPLANTABLE LOOP RECORDERS TO SUPPORT MARKET GROWTH 167
11 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION 169
11.1 INTRODUCTION 170
11.2 ARRHYTHMIAS 170
11.2.1 GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET 170
11.3 HEART FAILURE 172
11.3.1 GROWING PREVALENCE OF CHRONIC LIFESTYLE DISEASES TO DRIVE PREVALENCE OF HEART FAILURE 172
11.4 MYOCARDIAL INFARCTION (MI) 173
11.4.1 RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH 173
11.5 OTHER APPLICATIONS 175
12 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER 177
12.1 INTRODUCTION 178
12.2 HOSPITALS 178
12.2.1 INCREASING UTILIZATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES IN HOSPITALS TO AID MARKET GROWTH 178
12.3 PRIMARY CARE CENTERS 180
12.3.1 WIDENING ACCESS TO ECG MONITORING IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION 180
12.4 CARDIAC CENTERS 182
12.4.1 INCREASED INCIDENCE OF CARDIOVASCULAR DISEASE AND HIGH DEMAND FOR SPECIALIZED CARE TO BOOST MARKET GROWTH 182
12.5 AMBULATORY SURGICAL CENTERS 184
12.5.1 GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN AMBULATORY SURGICAL CENTERS TO INFLUENCE MARKET DEMAND 184
12.6 HOME CARE SETTINGS 186
12.6.1 RISING PREFERENCE FOR REMOTE CARDIAC MONITORING TO FUEL MARKET GROWTH 186
12.7 OTHER END USERS 187

13 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY REGION 189
13.1 INTRODUCTION 190
13.2 NORTH AMERICA 191
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 191
13.2.2 US 198
13.2.2.1 US to dominate North American cardiac monitoring and rhythm management devices market during forecast period 198
13.2.3 CANADA 204
13.2.3.1 High burden of cardiovascular diseases to support market growth 204
13.3 EUROPE 209
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 209
13.3.2 GERMANY 215
13.3.2.1 High healthcare spending to propel market growth 215
13.3.3 FRANCE 220
13.3.3.1 Favorable government initiatives to support market growth 220
13.3.4 UK 225
13.3.4.1 Rising demand for home-based smart ECG devices to support market growth 225
13.3.5 ITALY 230
13.3.5.1 Growing focus on improvements in patient care to drive market 230
13.3.6 SPAIN 235
13.3.6.1 Rising geriatric population to support market growth in Spain 235
13.3.7 AUSTRIA 241
13.3.7.1 Favourable insurance coverage for cardiac diagnostic procedures to support market growth 241
13.3.8 NETHERLANDS 246
13.3.8.1 Strong primary care referral pathway to aid adoption of cardiac monitoring and rhythm devices 246
13.3.9 SWEDEN 251
13.3.9.1 Expansion of long-term ambulatory ECG monitoring to augment market growth 251
13.3.10 REST OF EUROPE 256
13.4 ASIA PACIFIC 261
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 262
13.4.2 JAPAN 268
13.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth 268
13.4.3 CHINA 274
13.4.3.1 Government support for infrastructural improvement to drive market 274
13.4.4 INDIA 279
13.4.4.1 Increasing cardiac disease burden intensifies demand for cardiac monitoring and rhythm management devices 279
13.4.5 AUSTRALIA 285
13.4.5.1 Australia to strengthen community access to rhythm management devices through policy and targeted funding 285
13.4.6 SOUTH KOREA 290
13.4.6.1 Rising geriatric population to propel market growth 290
13.4.7 REST OF ASIA PACIFIC 296
13.5 LATIN AMERICA 301
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 302
13.5.2 BRAZIL 307
13.5.2.1 Improving access to diagnostic services to drive market growth 307
13.5.3 MEXICO 312
13.5.3.1 Rising incidences of heart disease to propel market growth 312
13.5.4 COLOMBIA 317
13.5.4.1 High arrhythmia burden to drive demand for cardiac rhythm monitoring in Colombia 317
13.5.5 REST OF LATIN AMERICA 322
13.6 MIDDLE EAST & AFRICA 327
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 332
13.6.2 GCC COUNTRIES 332
13.6.2.1 Kingdom of Saudi Arabia 338
13.6.2.1.1 High prevalence of cardiovascular diseases and increased demand for cardiac diagnostic solutions to drive market 338
13.6.2.2 UAE 343
13.6.2.2.1 Focus on national CVD screening programs and digital health strategies to augment market growth 343
13.6.2.3 Rest of GCC Countries 348
13.6.3 REST OF MIDDLE EAST & AFRICA 354
14 COMPETITIVE LANDSCAPE 360
14.1 INTRODUCTION 360
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 360
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 360
14.3 REVENUE ANALYSIS, 2022–2024 362
14.4 MARKET SHARE ANALYSIS, 2025 362
14.5 BRAND COMPARISON 366
14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 367
14.6.1 STARS 367
14.6.2 EMERGING LEADERS 367
14.6.3 PERVASIVE PLAYERS 367
14.6.4 PARTICIPANTS 367
14.6.5 COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024 369
14.6.5.1 Company footprint 369
14.6.5.2 Region footprint 370
14.6.5.3 Type footprint 371
14.6.5.4 Type footprint 372
14.6.5.5 Application footprint 373
14.7 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024 374
14.7.1 PROGRESSIVE COMPANIES 374
14.7.2 RESPONSIVE COMPANIES 374
14.7.3 DYNAMIC COMPANIES 374
14.7.4 STARTING BLOCKS 374
14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 376
14.7.5.1 Detailed list of key startups/SMEs 376
14.7.5.2 Competitive benchmarking of key startups/SMEs 376
14.8 COMPANY VALUATION & FINANCIAL METRICS 377
14.8.1 FINANCIAL METRICS 377
14.8.2 COMPANY VALUATION 377
14.9 COMPETITIVE SCENARIO 378
14.9.1 PRODUCT LAUNCHES & APPROVALS 378
14.9.2 DEALS 380
14.9.3 EXPANSIONS 382
14.9.4 OTHER DEVELOPMENTS 383
15 COMPANY PROFILES 385
15.1 KEY PLAYERS 385
15.1.1 GE HEALTHCARE 385
15.1.1.1 Business overview 385
15.1.1.2 Products offered 387
15.1.1.3 Recent developments 388
15.1.1.3.1 Deals 388
15.1.1.3.2 Other developments 389
15.1.1.4 MnM view 389
15.1.1.4.1 Right to win 389
15.1.1.4.2 Strategic choices 389
15.1.1.4.3 Weaknesses & competitive threats 390
15.1.2 KONINKLIJKE PHILIPS N.V. 391
15.1.2.1 Business overview 391
15.1.2.2 Products offered 392
15.1.2.3 Recent developments 395
15.1.2.3.1 Product launches 395
15.1.2.3.2 Deals 396
15.1.2.3.3 Expansions 397
15.1.2.3.4 Other developments 397

15.1.2.4 MnM view 397
15.1.2.4.1 Right to win 397
15.1.2.4.2 Strategic choices 398
15.1.2.4.3 Weaknesses & competitive threats 398
15.1.3 BOSTON SCIENTIFIC CORPORATION 399
15.1.3.1 Business overview 399
15.1.3.2 Products offered 400
15.1.3.3 Recent developments 402
15.1.3.3.1 Product approvals 402
15.1.3.3.2 Deals 403
15.1.3.4 MnM view 403
15.1.3.4.1 Right to win 403
15.1.3.4.2 Strategic choices 403
15.1.3.4.3 Weaknesses & competitive threats 403
15.1.4 BAXTER (HILL-ROM HOLDINGS, INC.) 404
15.1.4.1 Business overview 404
15.1.4.2 Products offered 405
15.1.5 MEDTRONIC 408
15.1.5.1 Business overview 408
15.1.5.2 Products offered 410
15.1.5.3 Recent developments 414
15.1.5.3.1 Product approvals 414
15.1.5.4 MnM view 415
15.1.5.4.1 Right to win 415
15.1.5.4.2 Strategic choices 415
15.1.5.4.3 Weaknesses & competitive threats 415
15.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 416
15.1.6.1 Business overview 416
15.1.6.2 Products offered 417
15.1.6.3 Recent developments 419
15.1.6.3.1 Product launches & approvals 419
15.1.6.3.2 Other developments 419
15.1.7 ABBOTT 420
15.1.7.1 Business overview 420
15.1.7.2 Products offered 421
15.1.7.3 Recent developments 423
15.1.7.3.1 Product launches & approvals 423

15.1.8 STRYKER 424
15.1.8.1 Business overview 424
15.1.8.2 Products offered 426
15.1.8.3 Recent developments 426
15.1.8.3.1 Product launches 426
15.1.8.3.2 Deals 427
15.1.8.3.3 Other developments 427
15.1.9 NIHON KOHDEN CORPORATION 428
15.1.9.1 Business overview 428
15.1.9.2 Products offered 429
15.1.10 MICROPORT SCIENTIFIC CORPORATION 432
15.1.10.1 Business overview 432
15.1.10.2 Products offered 433
15.1.10.3 Recent developments 435
15.1.10.3.1 Product launches and approvals 435
15.1.11 FUKUDA DENSHI 437
15.1.11.1 Business overview 437
15.1.11.2 Products offered 438
15.1.12 OSI SYSTEMS, INC. 441
15.1.12.1 Business overview 441
15.1.12.2 Products offered 442
15.1.12.3 Recent developments 444
15.1.12.3.1 Expansions 444
15.1.13 IRHYTHM INC. 445
15.1.13.1 Business overview 445
15.1.13.2 Products offered 446
15.1.13.3 Recent developments 446
15.1.13.3.1 Product launches and approvals 446
15.1.13.3.2 Deals 447
15.1.14 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 448
15.1.14.1 Business overview 448
15.1.14.2 Products offered 449
15.1.14.3 Recent developments 452
15.1.14.3.1 Product launches 452
15.1.15 ALIVECOR, INC. 453
15.1.15.1 Business overview 453
15.1.15.2 Products offered 453
15.1.15.3 Recent developments 454
15.1.15.3.1 Product launches and approvals 454
15.1.15.3.2 Deals 454

15.2 OTHER PLAYERS 456
15.2.1 SCHILLER 456
15.2.2 CARDIAC INSIGHT, INC. 457
15.2.3 BIOTRONIK 458
15.2.4 BITTIUM 459
15.2.5 BPL MEDICAL TECHNOLOGIES 460
15.2.6 LIFESIGNALS 461
15.2.7 CUMEDICAL 462
15.2.8 BIOTRICITY 463
15.2.9 EDAN INSTRUMENTS, INC. 464
15.2.10 VITALCONNECT 465
16 RESEARCH METHODOLOGY 466
16.1 RESEARCH DATA 466
16.1.1 SECONDARY DATA 467
16.1.1.1 Key secondary sources 467
16.1.1.2 Key data from secondary sources 468
16.1.2 PRIMARY DATA 468
16.1.2.1 Primary sources 469
16.1.2.2 Key objectives of primary research 469
16.1.2.3 Key industry insights 470
16.1.2.4 Breakdown of primaries 471
16.2 MARKET SIZE ESTIMATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 472
16.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 472
16.2.2 MNM REPOSITORY ANALYSIS 473
16.2.3 COMPANY INVESTORS PRESENTATIONS AND PRIMARY INTERVIEWS 473
16.2.4 TOP-DOWN APPROACH 473
16.2.5 BOTTOM-UP APPROACH 474
16.2.6 PRIMARY INTERVIEWS 474
16.2.7 DEMAND-SIDE APPROACH 475
16.3 MARKET GROWTH RATE PROJECTION 475
16.4 DATA TRIANGULATION 476
16.4.1 STUDY ASSUMPTIONS 478
16.4.2 RESEARCH LIMITATIONS 478
16.5 RISK ANALYSIS 479

17 APPENDIX 480
17.1 DISCUSSION GUIDE 480
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 486
17.3 CUSTOMIZATION OPTIONS 488
17.3.1 COMPANY INFORMATION 488
17.3.2 GEOGRAPHIC ANALYSIS 488
17.3.3 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 488
17.3.4 COUNTRY-LEVEL VOLUME ANALYSIS 488
17.3.5 ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST 488
17.4 RELATED REPORTS 489
17.5 AUTHOR DETAILS 490

LIST OF TABLES

TABLE 1 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: INCLUSIONS & EXCLUSIONS 45
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 46
TABLE 3 PRODUCT RECALLS BY US FDA, 2022–2025 63
TABLE 4 IMPACT OF PORTER’S FIVE FORCES ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 67
TABLE 5 GDP CHANGE, BY COUNTRY, 2021–2030 (USD BILLION) 69
TABLE 6 ROLE OF KEY COMPANIES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET ECOSYSTEM 74
TABLE 7 AVERAGE SELLING PRICE TREND OF HOLTER MONITORS, BY REGION,
2023–2025 (USD) 76
TABLE 8 AVERAGE SELLING PRICE TREND 0F EXTERNAL DEFIBRILLATORS, BY REGION, 2023–2025 ((USD) 77
TABLE 9 IMPORT DATA FOR HS CODE 901811, BY COUNTRY,
2021–2024 (USD THOUSAND) 78
TABLE 10 EXPORT DATA FOR HS CODE 901811, BY COUNTRY,
2021–2024 (USD THOUSAND) 78
TABLE 11 MAJOR CONFERENCES & EVENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, JANUARY 2025–DECEMBER 2026 79
TABLE 12 CASE STUDY 1: DUAL-CHAMBER LEADLESS PACEMAKER BY ABBOTT 81
TABLE 13 CASE STUDY 2: CARDIOSOFT ECG-BICESTER HEALTH CENTRE IN NUMED HEALTHCARE 81
TABLE 14 CASE STUDY 3: POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT 82
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024 84
TABLE 16 KEY PRODUCT-RELATED TARIFF EFFECTIVE 84
TABLE 17 IMPACT OF US TARIFF ON CANADA 85
TABLE 18 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 85
TABLE 19 IMPACT OF US TARIFF ON GERMANY AND UK 86
TABLE 20 IMPACT OF US TARIFF ON MEXICO 87
TABLE 21 KEY PATENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2023–2025 94
TABLE 22 BEST PRACTICES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 99
TABLE 23 CASE STUDIES RELATED TO AI IMPLEMENTATION IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 100
TABLE 24 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 101
TABLE 25 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 26 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 27 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
TABLE 28 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 29 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 30 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 110
TABLE 31 KEY BUYING CRITERIA FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 111
TABLE 32 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 116
TABLE 33 RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE,
2024–2031 (USD MILLION) 116
TABLE 34 RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 35 SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 119
TABLE 36 DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 121
TABLE 37 LEADLESS CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 123
TABLE 38 RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE,
2024–2031 (USD MILLION) 124
TABLE 39 RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY COUNTRY, 2024–2031(USD MILLION) 125
TABLE 40 KEY COMMERCIAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 126
TABLE 41 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 127
TABLE 42 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 128
TABLE 43 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130
TABLE 44 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 45 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 46 KEY COMMERCIAL EXTERNAL DEFIBRILLATORS 135
TABLE 47 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE , 2024–2031 (USD MILLION) 135
TABLE 48 EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136
TABLE 49 AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 138
TABLE 50 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 140
TABLE 51 WEARABLE CARDIOVERTER DEFIBRILLATORS (WCDS) MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 52 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 143
TABLE 53 CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P) MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 144
TABLE 54 CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS (CRT-D) MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 55 RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 148
TABLE 56 ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 149
TABLE 57 ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 150
TABLE 58 ELECTROCARDIOGRAM (ECG/EKG) MONITORS VOLUME, BY COUNTRY,
2024–2031 (THOUSAND UNITS) 151
TABLE 59 STANDARD 12-LEAD ECG MACHINES (RESTING ECG MONITORS) MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 60 STRESS ECG SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 61 STRESS ECG SYSTEMS VOLUME, BY COUNTRY, 2024–2031 (THOUSAND UNITS) 155
TABLE 62 HANDHELD/SMART ECG MONITORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 156
TABLE 63 AMBULATORY CARDIAC MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 157
TABLE 64 AMBULATORY CARDIAC MONITORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 158
TABLE 65 HOLTER MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 66 EVENT MONITORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162
TABLE 67 MOBILE CARDIAC TELEMETRY (MCT) DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 164
TABLE 68 LONG-TERM CONTINUOUS ECG MONITORS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 166
TABLE 69 INVASIVE CARDIAC MONITORING DEVICES MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 168
TABLE 70 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 170
TABLE 71 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR ARRHYTHMIAS, BY COUNTRY, 2024–2031 (USD MILLION) 171
TABLE 72 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR
HEART FAILURE, BY COUNTRY, 2024–2031 (USD MILLION) 173
TABLE 73 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR MYOCARDIAL INFARCTION (MI), 2024–2031 (USD MILLION) 174
TABLE 74 CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 176
TABLE 75 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 178
TABLE 76 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 179
TABLE 77 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR PRIMARY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 181
TABLE 78 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC CENTERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 183
TABLE 79 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY/REGION,
2024–2031 (USD MILLION) 185
TABLE 80 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION) 187
TABLE 81 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 188
TABLE 82 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY REGION, 2024–2031 (USD MILLION) 190
TABLE 83 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 84 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 193
TABLE 85 NORTH AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 193
TABLE 86 NORTH AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 194
TABLE 87 NORTH AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 88 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 195
TABLE 89 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 90 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 91 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 92 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR EXTERNAL DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 93 NORTH AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 94 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 197
TABLE 95 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 198
TABLE 96 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 97 US: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 98 US: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 99 US: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 200
TABLE 100 US: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 101 US: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 102 US: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 103 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 104 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 105 US: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 106 US: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 203
TABLE 107 US: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 203
TABLE 108 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 109 CANADA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 110 CANADA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 111 CANADA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 205
TABLE 112 CANADA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 113 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 114 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 115 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 116 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 117 CANADA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 118 CANADA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 208
TABLE 119 CANADA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 209
TABLE 120 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210
TABLE 121 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 122 EUROPE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 123 EUROPE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 124 EUROPE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 125 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 126 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 127 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 128 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 129 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 130 EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 131 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 214
TABLE 132 EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 215
TABLE 133 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 216
TABLE 134 GERMANY: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 135 GERMANY: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 136 GERMANY: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 137 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 138 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS,
BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 139 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 140 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 141 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 142 GERMANY: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 143 GERMANY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219
TABLE 144 GERMANY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 220
TABLE 145 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 221
TABLE 146 FRANCE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 147 FRANCE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 221
TABLE 148 FRANCE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 222
TABLE 149 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 222
TABLE 150 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 151 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 152 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 153 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 154 FRANCE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 155 FRANCE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 224
TABLE 156 FRANCE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 225
TABLE 157 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 158 UK: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 226
TABLE 159 UK: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 226
TABLE 160 UK: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 226
TABLE 161 UK: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 227
TABLE 162 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 163 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 164 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 165 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 166 UK: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 167 UK: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 229
TABLE 168 UK: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 230
TABLE 169 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 170 ITALY: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 171 ITALY: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 172 ITALY: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 232
TABLE 173 ITALY: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 232
TABLE 174 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 175 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 176 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 177 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 178 ITALY: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 179 ITALY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 235
TABLE 180 ITALY: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 235
TABLE 181 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 182 SPAIN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 183 SPAIN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 184 SPAIN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 237
TABLE 185 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 186 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 187 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 188 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 189 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 190 SPAIN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 191 SPAIN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 240
TABLE 192 SPAIN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 241
TABLE 193 AUSTRIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 194 AUSTRIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 242
TABLE 195 AUSTRIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 196 AUSTRIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 243
TABLE 197 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 243
TABLE 198 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 199 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 200 AUSTRIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 201 AUSTRIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 202 AUSTRIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 245
TABLE 203 AUSTRIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 245
TABLE 204 AUSTRIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 246
TABLE 205 NETHERLANDS: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 247
TABLE 206 NETHERLANDS: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 207 NETHERLANDS: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 208 NETHERLANDS: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 248
TABLE 209 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 248
TABLE 210 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS,
BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 211 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 212 NETHERLANDS: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 213 NETHERLANDS: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 214 NETHERLANDS: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 215 NETHERLANDS: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 251
TABLE 216 NETHERLANDS: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 251
TABLE 217 SWEDEN: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 252
TABLE 218 SWEDEN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 219 SWEDEN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 220 SWEDEN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 253
TABLE 221 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 253
TABLE 222 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 223 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 224 SWEDEN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 225 SWEDEN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 226 SWEDEN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 227 SWEDEN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 255
TABLE 228 SWEDEN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 256
TABLE 229 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 230 REST OF EUROPE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 231 REST OF EUROPE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 257
TABLE 232 REST OF EUROPE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 258
TABLE 233 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 258
TABLE 234 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 235 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 236 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 237 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 260
TABLE 238 REST OF EUROPE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 260
TABLE 239 REST OF EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 261
TABLE 240 REST OF EUROPE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 261
TABLE 241 ASIA PACIFIC: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 263
TABLE 242 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 264
TABLE 243 ASIA PACIFIC: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 244 ASIA PACIFIC: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION 264
TABLE 245 ASIA PACIFIC: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 265
TABLE 246 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 265
TABLE 247 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS,
BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 248 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 249 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 266
TABLE 250 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 251 ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 252 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 268
TABLE 253 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 268
TABLE 254 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 269
TABLE 255 JAPAN: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 269
TABLE 256 JAPAN: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 257 JAPAN: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 270
TABLE 258 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 270
TABLE 259 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 260 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 261 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 262 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 272
TABLE 263 JAPAN: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 264 JAPAN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 273
TABLE 265 JAPAN: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 274
TABLE 266 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 267 CHINA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 268 CHINA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 275
TABLE 269 CHINA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 276
TABLE 270 CHINA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 276
TABLE 271 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 272 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 273 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 274 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 278
TABLE 275 CHINA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 276 CHINA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 279
TABLE 277 CHINA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 279
TABLE 278 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 280
TABLE 279 INDIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 280
TABLE 280 INDIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 281
TABLE 281 INDIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 281
TABLE 282 INDIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 281
TABLE 283 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 284 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 285 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 286 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 287 INDIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 288 INDIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 284
TABLE 289 INDIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 285
TABLE 290 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 286
TABLE 291 AUSTRALIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 292 AUSTRALIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 293 AUSTRALIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 287
TABLE 294 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 295 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS,
BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 296 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 297 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 298 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 289
TABLE 299 AUSTRALIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 300 AUSTRALIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 290
TABLE 301 AUSTRALIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 290
TABLE 302 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 291
TABLE 303 SOUTH KOREA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 304 SOUTH KOREA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 305 SOUTH KOREA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 306 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 307 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS,
BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 308 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 309 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 310 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 294
TABLE 311 SOUTH KOREA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 312 SOUTH KOREA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 295
TABLE 313 SOUTH KOREA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 296
TABLE 314 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 315 REST OF ASIA PACIFIC: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 316 REST OF ASIA PACIFIC: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 317 REST OF ASIA PACIFIC: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 298
TABLE 318 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 319 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 320 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 321 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 322 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 300
TABLE 323 REST OF ASIA PACIFIC: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 324 REST OF ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 301
TABLE 325 REST OF ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 301
TABLE 326 LATIN AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 302
TABLE 327 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 302
TABLE 328 LATIN AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 329 LATIN AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 330 LATIN AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 303
TABLE 331 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 304
TABLE 332 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS,
BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 333 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 334 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 335 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 336 LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 337 LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 306
TABLE 338 LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 307
TABLE 339 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 308
TABLE 340 BRAZIL: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 308
TABLE 341 BRAZIL: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 308
TABLE 342 BRAZIL: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 309
TABLE 343 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 309
TABLE 344 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 345 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 346 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 347 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 311
TABLE 348 BRAZIL: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 349 BRAZIL: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 311
TABLE 350 BRAZIL: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 312
TABLE 351 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 313
TABLE 352 MEXICO: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 313
TABLE 353 MEXICO: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 313
TABLE 354 MEXICO: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 314
TABLE 355 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 314
TABLE 356 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 357 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 358 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 359 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 316
TABLE 360 MEXICO: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 316
TABLE 361 MEXICO: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 316
TABLE 362 MEXICO: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 317
TABLE 363 COLOMBIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 318
TABLE 364 COLOMBIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 365 COLOMBIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 366 COLOMBIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 319
TABLE 367 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 319
TABLE 368 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS,
BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 369 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS,
BY TYPE, 2024–2031 (USD MILLION) 320
TABLE 370 COLOMBIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 320
TABLE 371 COLOMBIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 321
TABLE 372 COLOMBIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 373 COLOMBIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 321
TABLE 374 COLOMBIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 322
TABLE 375 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 376 REST OF LATIN AMERICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 323
TABLE 377 REST OF LATIN AMERICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 323
TABLE 378 REST OF LATIN AMERICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 323
TABLE 379 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 380 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 381 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 382 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 383 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 325
TABLE 384 REST OF LATIN AMERICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 326
TABLE 385 REST OF LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 326
TABLE 386 REST OF LATIN AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 326
TABLE 387 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET, BY REGION, 2024–2031 (USD MILLION) 327
TABLE 388 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 389 MIDDLE EAST & AFRICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 328
TABLE 390 MIDDLE EAST & AFRICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 328
TABLE 391 MIDDLE EAST & AFRICA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 328
TABLE 392 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 393 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 394 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 395 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 396 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 330
TABLE 397 MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 398 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 331
TABLE 399 MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 332
TABLE 400 GCC COUNTRIES: CARDIAC MONITORING AND CARDIAC RHYTHM MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 333
TABLE 401 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 333
TABLE 402 GCC COUNTRIES: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 403 GCC COUNTRIES: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 404 GCC COUNTRIES: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 334
TABLE 405 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 335
TABLE 406 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 407 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 408 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 409 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 336
TABLE 410 GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 411 GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 337
TABLE 412 GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 338
TABLE 413 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 414 KINGDOM OF SAUDI ARABIA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 415 KINGDOM OF SAUDI ARABIA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 416 KINGDOM OF SAUDI ARABIA: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 340
TABLE 417 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 418 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 419 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 341
TABLE 420 KINGDOM OF SAUDI ARABIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 341
TABLE 421 KINGDOM OF SAUDI ARABIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 422 KINGDOM OF SAUDI ARABIA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE,
2024–2031 (USD MILLION) 342
TABLE 423 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 343
TABLE 424 KINGDOM OF SAUDI ARABIA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 343
TABLE 425 UAE: CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 344
TABLE 426 UAE: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 344
TABLE 427 UAE: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 344
TABLE 428 UAE: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE
2024–2031 (USD MILLION) 345
TABLE 429 UAE: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE,
2024–2031 (USD MILLION) 345
TABLE 430 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 345
TABLE 431 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 346
TABLE 432 UAE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 346
TABLE 433 UAE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 347
TABLE 434 UAE: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE, 2024–2031 (USD MILLION) 347
TABLE 435 UAE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 348
TABLE 436 UAE: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET,
BY END USER, 2024–2031 (USD MILLION) 348
TABLE 437 REST OF GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 438 REST OF GCC COUNTRIES: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 439 REST OF GCC COUNTRIES: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 350
TABLE 440 REST OF GCC COUNTRIES: AMBULATORY CARDIAC MONITORS MARKET, BY TYPE 2024–2031 (USD MILLION) 350
TABLE 441 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 350
TABLE 442 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 351
TABLE 443 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 351
TABLE 444 REST OF GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 352
TABLE 445 REST OF GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 352
TABLE 446 REST OF GCC COUNTRIES: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE,
2024–2031 (USD MILLION) 353
TABLE 447 REST OF GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 353
TABLE 448 REST OF GCC COUNTRIES: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 354
TABLE 449 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 355
TABLE 450 REST OF MIDDLE EAST & AFRICA: NON-INVASIVE CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 355
TABLE 451 REST OF MIDDLE EAST & AFRICA: ELECTROCARDIOGRAM (ECG/EKG) MONITORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 355
TABLE 452 REST OF MIDDLE EAST & AFRICA: AMBULATORY CARDIAC MONITORS MARKET,
BY TYPE 2024–2031 (USD MILLION) 356
TABLE 453 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 356
TABLE 454 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR PACEMAKERS, BY TYPE, 2024–2031 (USD MILLION) 356
TABLE 455 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR DEFIBRILLATORS, BY TYPE, 2024–2031 (USD MILLION) 357
TABLE 456 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD) MARKET, BY TYPE, 2024–2031 (USD MILLION) 357
TABLE 457 REST OF MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 358
TABLE 458 REST OF MIDDLE EAST & AFRICA: RHYTHM MANAGEMENT DEVICES MARKET FOR CARDIAC RESYNCHRONIZATION THERAPY (CRT), BY TYPE,
2024–2031 (USD MILLION) 358
TABLE 459 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 359
TABLE 460 REST OF MIDDLE EAST & AFRICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 359
TABLE 461 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 360
TABLE 462 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION, 2025 363
TABLE 463 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: REGION FOOTPRINT 370
TABLE 464 CARDIAC MONITORING DEVICES MARKET: TYPE FOOTPRINT 371
TABLE 465 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: TYPE FOOTPRINT 372
TABLE 466 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: APPLICATION FOOTPRINT 373
TABLE 467 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
DETAILED LIST OF KEY STARTUPS/SME PLAYERS 376
TABLE 468 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS,
BY TYPE AND REGION 376
TABLE 469 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–NOVEMBER 2025 378
TABLE 470 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
DEALS, JANUARY 2023–NOVEMBER 2025 380
TABLE 471 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2023–NOVEMBER 2025 382
TABLE 472 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
OTHER DEVELOPMENTS, JANUARY 2023–NOVEMBER 2025 383
TABLE 473 GE HEALTHCARE: COMPANY OVERVIEW 385
TABLE 474 GE HEALTHCARE: PRODUCTS OFFERED 387
TABLE 475 GE HEALTHCARE: DEALS, JANUARY 2023–JANUARY 2026 388
TABLE 476 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 389
TABLE 477 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 391
TABLE 478 KONINKLIJKE PHILIPS N. V.: PRODUCTS OFFERED 392
TABLE 479 KONINKLIJKE PHILIPS N. V.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 395
TABLE 480 KONINKLIJKE PHILIPS N. V.: DEALS, JANUARY 2023–JANUARY 2026 396
TABLE 481 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023–JANUARY 2026 397
TABLE 482 KONINKLIJKE PHILIPS N. V.: OTHER DEVELOPMENTS,
JANUARY 2023–JANUARY 2026 397
TABLE 483 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 399
TABLE 484 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 400
TABLE 485 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2023–JANUARY 2026 402
TABLE 486 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023–JANUARY 2026 403
TABLE 487 BAXTER (HILL-ROM HOLDINGS, INC.): COMPANY OVERVIEW 404
TABLE 488 BAXTER (HILL-ROM HOLDINGS, INC.): PRODUCTS OFFERED 405
TABLE 489 MEDTRONIC: COMPANY OVERVIEW 408
TABLE 490 MEDTRONIC: PRODUCTS OFFERED 410
TABLE 491 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2023–JANUARY 2026 414
TABLE 492 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 416
TABLE 493 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 417
TABLE 494 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JANUARY 2026 419
TABLE 495 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 419
TABLE 496 ABBOTT: COMPANY OVERVIEW 420
TABLE 497 ABBOTT: PRODUCTS OFFERED 421
TABLE 498 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JANUARY 2026 423
TABLE 499 STRYKER: COMPANY OVERVIEW 424
TABLE 500 STRYKER: PRODUCTS OFFERED 426
TABLE 501 STRYKER: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 426
TABLE 502 STRYKER: DEALS, JANUARY 2023–JANUARY 2026 427
TABLE 503 STRYKER: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 427
TABLE 504 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 428
TABLE 505 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 429
TABLE 506 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 432
TABLE 507 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 433
TABLE 508 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–JANUARY 2026 435
TABLE 509 FUKUDA DENSHI: COMPANY OVERVIEW 437
TABLE 510 FUKUDA DENSHI: PRODUCTS OFFERED 438
TABLE 511 OSI SYSTEMS, INC.: COMPANY OVERVIEW 441
TABLE 512 OSI SYSTEMS, INC.: PRODUCTS OFFERED 442
TABLE 513 OSI SYSTEMS, INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026 444
TABLE 514 IRHYTHM INC.: COMPANY OVERVIEW 445
TABLE 515 IRHYTHM INC.: PRODUCTS OFFERED 446
TABLE 516 IRHYTHM INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023–JANUARY 2026 446
TABLE 517 IRHYTHM INC.: DEALS, JANUARY 2023–JANUARY 2026 447
TABLE 518 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW 448
TABLE 519 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCTS OFFERED 449
TABLE 520 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: PRODUCT LAUNCHES,
JANUARY 2023–JANUARY 2026 452
TABLE 521 ALIVECOR, INC.: COMPANY OVERVIEW 453
TABLE 522 ALIVECOR, INC.: PRODUCTS OFFERED 453
TABLE 523 ALIVECOR, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023–JANUARY 2026 454
TABLE 524 ALIVECOR, INC.: DEALS, JANUARY 2023–JANUARY 2026 454
TABLE 525 SCHILLER: COMPANY OVERVIEW 456
TABLE 526 CARDIAC INSIGHT, INC.: COMPANY OVERVIEW 457
TABLE 527 BIOTRONIK: COMPANY OVERVIEW 458
TABLE 528 BITTIUM: COMPANY OVERVIEW 459
TABLE 529 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 460
TABLE 530 LIFESIGNALS: COMPANY OVERVIEW 461
TABLE 531 CUMEDICAL: COMPANY OVERVIEW 462
TABLE 532 BIOTRICITY: COMPANY OVERVIEW 463
TABLE 533 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW 464
TABLE 534 VITALCONNECT: COMPANY OVERVIEW 465
TABLE 535 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
STUDY ASSUMPTIONS 478
TABLE 536 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
RISK ANALYSIS 479

LIST OF FIGURES

FIGURE 1 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SEGMENTATION & REGIONAL SCOPE 44
FIGURE 2 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
YEARS CONSIDERED 45
FIGURE 3 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SCENARIO 49
FIGURE 4 GLOBAL CARDIAC MONITORING AND RHYTHM MANAGEMENT MARKET DEVICES MARKET SIZE, 2024–2031 (USD MILLION) 49
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2022–2025 50
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 51
FIGURE 7 HIGH-GROWTH SEGMENTS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2026–2031 52
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR, IN TERMS OF VALUE, DURING FORECAST PERIOD 53
FIGURE 9 HIGH CARDIOVASCULAR DISEASE INCIDENCE AND SHIFT TOWARD CONTINUOUS MONITORING TO ACCELERATE MARKET EXPANSION 54
FIGURE 10 CHINA AND ARRHYTHMIA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 55
FIGURE 11 INDIA TO WITNESS HIGHEST CAGR FROM 2026 TO 2031 56
FIGURE 12 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
FIGURE 13 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 14 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
SUPPLY CHAIN ANALYSIS 71
FIGURE 15 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
VALUE CHAIN ANALYSIS 72
FIGURE 16 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: ECOSYSTEM ANALYSIS 73
FIGURE 17 AVERAGE SELLING PRICE OF HOLTER MONITORS, BY KEY PLAYER, 2025 (USD) 75
FIGURE 18 AVERAGE SELLING PRICE OF EXTERNAL DEFIBRILLATORS, BY KEY PLAYER,
2024 (USD) 76
FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET 80
FIGURE 20 INVESTMENT AND FUNDING SCENARIO FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET PLAYERS 80
FIGURE 21 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
PATENT ANALYSIS, JANUARY 2014–NOVEMBER 2025 93
FIGURE 22 AI USE CASES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT
DEVICES MARKET 97
FIGURE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES 110
FIGURE 24 KEY BUYING CRITERIA FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICE PLAYERS 111
FIGURE 25 NORTH AMERICA: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT 192
FIGURE 26 ASIA PACIFIC: CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT 263
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, 2022–2024 (USD MILLION) 362
FIGURE 28 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025) 363
FIGURE 29 US CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025) 365
FIGURE 30 EUROPE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS (2025) 365
FIGURE 31 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
BRAND COMPARATIVE ANALYSIS 366
FIGURE 32 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 368
FIGURE 33 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
COMPANY FOOTPRINT 369
FIGURE 34 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 375
FIGURE 35 EV/EBITDA OF KEY VENDORS 377
FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 377
FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT 386
FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 392
FIGURE 39 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 400
FIGURE 40 BAXTER (HILL-ROM HOLDINGS, INC.): COMPANY SNAPSHOT 405
FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT 409
FIGURE 42 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT 417
FIGURE 43 ABBOTT: COMPANY SNAPSHOT 421
FIGURE 44 STRYKER: COMPANY SNAPSHOT 425
FIGURE 45 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 429
FIGURE 46 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 433
FIGURE 47 FUKUDA DENSHI: COMPANY SNAPSHOT 438
FIGURE 48 OSI SYSTEMS, INC.: COMPANY SNAPSHOT 442
FIGURE 49 IRHYTHM INC.: COMPANY SNAPSHOT 445
FIGURE 50 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT 449
FIGURE 51 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET: RESEARCH DESIGN 466
FIGURE 52 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
KEY DATA FROM SECONDARY SOURCES 468
FIGURE 53 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
KEY PRIMARY SOURCES 469
FIGURE 54 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
INSIGHTS FROM KEY PRIMARIES 470
FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 471
FIGURE 56 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 471
FIGURE 57 CARDIAC MONITORING DEVICES MARKET (INVASIVE AND NON-INVASIVE DEVICE TYPE) SIZE ESTIMATION: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) 472
FIGURE 58 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
TOP-DOWN APPROACH 474
FIGURE 59 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
BOTTOM-UP APPROACH 474
FIGURE 60 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
CAGR PROJECTIONS (SUPPLY SIDE) 476
FIGURE 61 CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET:
DATA TRIANGULATION METHODOLOGY 477

---

---